Yes I do. So we should just paint the call as negative?

New Post Public Reply Private Reply Replies (2) Message Board
Riztheinvestor Hulk767 #129925
518
Yes I do.

So we should just paint the call as negative? I’m sorry but “There was no detail on NASH partnership, cancer partnership, or anything else on that front. “ I’m about to rant. Hear me out.

Why would there be details on partnership or anything you mentioned as it falls under NDAs? You know when we will find out the details of it? When the announcement is made. Which is when? That’s right nobody knows. It could happen tomorrow or next month or a year. You know who would know ? Cyrus.

So when you say there’s nothing positive I don’t believe you were listing. Cyrus clearly said he has something to share with us next ASM. What was Cyrus saying ? I don’t see how you don’t see that as positive. We will get an update on NASH and he said that he was excited.

What could be so exciting about NASH. We’ve only been waiting for an actual update all year and never got it.

So yea the call was positive because once again Cyrus was reinforcing what we have to look forward to. Cyrus knew that the BLA had a high chance of not being successful and still joined. It’s in the past. HIV is still going to be treated with Leronlimab just not as soon as we want and not specifically in the MDR pop.

Big set back but clearly it’s 2 steps back and 5 steps forward. 2022 is the year of bad news. Before Cyrus becomes CEO something positive has to happen. Right ? Or he won’t be CEO. Cyrus has been paying with a stacked deck the entire time. Like this guys doesn’t know something positive is taking place. Give me a break, nobody in their right mind would want to be a CEO of this company unless they had some serious information share holders aren’t aware of.

Only a few things can get us out of this giant whole we are in. Which mind you, could be right where our competitors wanted us to begin with to make a deal.

Acquisition, partnership, buyout or major financing deal. If these things don’t work out, then so much for “increasing shareholder value” as Cyrus so perfectly stated several times. If these things don’t workout then we have, bankruptcy, dilution or a reverse split to look forward to. Guess what I’d be betting the later.

This is why I think the call was positive. People are too busy looking at all the negative in this company. Mind you there is a ton. Covid failed, HIV ( Specifically MDR pop BLA was a no go) and we have almost no money and a ton owed to a lot of people. Im guilty myself of this thinking like this because of shorts and I have way too much invested here. When the news was dropped Friday I was ready to sell. That was my initial reaction.

However, I am glad I had time to think about my investment. Even better I’m happy Cyrus has something he is excited to share with us during the next meeting. As he’s said he is a man of action. With all of this being said I look forward to getting all the bad behind us and to some positive news coming. All he did is reinforce what I already thought about the company as a whole.

So yes the CC in my opinion was necessary and also gave me the confidence not only to not give into the shorts and flippers, it gave me the necessary information to add to my position when I have the funds. People are giving their shares away. Not me…
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
Dr. Rashedi Reveals Laughing Gas Safety for Kids

Updated Category News Views 0

Why Laughing Gas is a Game-Changer in Pediatric Dentistry You ever seen a kid freeze up like a deer in headlights at the dentist's office? I'm telling you, it's not just the sweet tooth nightmare but often the fear of that cold, intimidating chair. But let's talk about a game-changer: laughing gas or, known in the trade as nitrous oxide. Keeping Anxiety at Bay: The Role...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 1

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Updated Category News Views 0

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

Continue Reading
XCOTTON Shines at IFA 2026: The New Horizon of Commerce

Updated Category News Views 1

Shifting Gears at the Checkout Counter Let's face it, we've all been there: you click, you pay, and then you wait. But what happens next is where brands often drop the ball. Sure, e-commerce has been all about getting us to trust the 'buy' button. That's where folks like XCOTTON are stepping up to the plate, giving us something else to consider. They were loud and clear...

Continue Reading
Dreame Unveils Vast AI Product Range at IFA 2026

Updated Category News Views 0

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 4

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
AVEX Faces Lawsuit Over IPO Missteps

Updated Category News Views 3

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...

Continue Reading
ing Brands Faces Legal Probe; Fiduciary Duties Questioned"> Continue Reading